Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-23460
Rakovic, A; Stiller, B; Djarmati, A; Flaquer, A; Freudenberg, J; Toliat, M R; Linnebank, M; Kostic, V; Lohmann, K; Paus, S; Nürnberg, P; Kubisch, C; Klein, C; Wüllner, U; Ramirez, A (2009). Genetic association study of the P-type ATPase ATP13A2 in late-onset Parkinson's disease. Movement Disorders, 24(3):429-433.
A role of ATP13A2 in early-onset Parkinsonism (EOP) has been proposed. Conversely, the contribution of this ATPase to late-onset Parkinson's disease (PD) remains unexplored. We therefore conducted a case-control association study in this age-of-onset group with PD. The initial sample was of German origin and consisted of 220 patients with late-onset PD (mean age of onset 60.1 years) and 232 age-matched unrelated controls. Five single nucleotide polymorphisms (SNPs) covering ATP13A2 and its common haplotypes were genotyped. The overall association results in this sample were negative. Interestingly, gender stratification gave a positive result for SNP rs11203280 (P(UNC) = 0.016) in men. This result could not be reproduced in a replication sample of German and Serbian origin composed of 161 patients with late-onset PD (mean age of onset 51.7 years) and 150 age- and ethnic-matched controls. In conclusion, we found no consistent evidence for an association between ATP13A2 and late-onset PD.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology|
|DDC:||610 Medicine & health|
|Deposited On:||02 Nov 2009 11:06|
|Last Modified:||27 Nov 2013 21:33|
|Additional Information:||The definitive version is available at www.blackwell-synergy.com|
|Citations:||Web of Science®. Times cited: 5|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page